Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,813 | 14,311 | 46,329 | 71,144 | 250,728 |
| Marketable Securities | 28,300 | 130,983 | 206,669 | 330,171 | 160,915 |
| Receivables | 1,199 | 2,405 | 11,738 | 8,032 | 19,064 |
| TOTAL | $97,830 | $153,113 | $315,243 | $448,445 | $471,171 |
| Non-Current Assets | |||||
| PPE Net | 3,660 | 4,961 | 7,728 | 17,453 | 11,348 |
| Investments And Advances | 1,614 | 2,780 | 2,007 | 3,907 | 4,895 |
| Intangibles | 0 | 0 | 12,643 | 13,140 | 13,660 |
| Other Non-Current Assets | 10,094 | 10,097 | 10,912 | 12,997 | 38,699 |
| TOTAL | $15,367 | $17,838 | $33,291 | $47,497 | $68,602 |
| Total Assets | $113,197 | $170,951 | $348,533 | $495,942 | $539,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,551 | 20,918 | 80,907 | 48,193 | 21,847 |
| Accrued Expenses | 2,022 | 2,365 | 10,594 | 10,326 | 9,950 |
| Other current liabilities | 13,255 | N/A | N/A | N/A | N/A |
| TOTAL | $35,326 | $42,570 | $96,868 | $65,742 | $41,706 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,516 |
| Deferred Revenues | N/A | 109 | 2,563 | 4,619 | 7,579 |
| Other Non-Current Liabilities | 9,368 | 11,032 | 29,271 | 30,434 | 33,325 |
| TOTAL | $9,368 | $11,032 | $29,303 | $30,530 | $36,926 |
| Total Liabilities | $44,693 | $53,602 | $126,171 | $96,272 | $78,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,667 | 23,370 | 21,669 | 18,110 | 17,296 |
| Common Shares | 36 | 23 | 21 | 217 | 187 |
| Retained earnings | -1,730,219 | -1,622,965 | -1,487,848 | -1,209,855 | -906,197 |
| Other shareholders' equity | -676 | -663 | -698 | -283 | -256 |
| TOTAL | $68,504 | $117,349 | $222,363 | $399,669 | $461,141 |
| Total Liabilities And Equity | $113,197 | $170,951 | $348,533 | $495,942 | $539,772 |